Peripheral Intervention Drug-Eluting Devices Market

List of Tables
Table 1. Peripheral Intervention Drug-Eluting Devices CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Peripheral Intervention Drug-Eluting Devices Market Trends
Table 3. Peripheral Intervention Drug-Eluting Devices Market Drivers
Table 4. Peripheral Intervention Drug-Eluting Devices Market Challenges
Table 5. Peripheral Intervention Drug-Eluting Devices Market Restraints
Table 6. Global Peripheral Intervention Drug-Eluting Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Peripheral Intervention Drug-Eluting Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Peripheral Intervention Drug-Eluting Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Peripheral Intervention Drug-Eluting Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Peripheral Intervention Drug-Eluting Devices Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturer, 2017-2022
Table 13. Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Manufacturer, 2017-2022
Table 15. Global Peripheral Intervention Drug-Eluting Devices Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Peripheral Intervention Drug-Eluting Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Peripheral Intervention Drug-Eluting Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2021)
Table 18. Top Players of Peripheral Intervention Drug-Eluting Devices in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Peripheral Intervention Drug-Eluting Devices Product Type
Table 20. Date of International Manufacturers Enter into Peripheral Intervention Drug-Eluting Devices Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Peripheral Intervention Drug-Eluting Devices Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Peripheral Intervention Drug-Eluting Devices Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Peripheral Intervention Drug-Eluting Devices Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Peripheral Intervention Drug-Eluting Devices Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Peripheral Intervention Drug-Eluting Devices Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Peripheral Intervention Drug-Eluting Devices Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Peripheral Intervention Drug-Eluting Devices Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Peripheral Intervention Drug-Eluting Devices Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Peripheral Intervention Drug-Eluting Devices Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Peripheral Intervention Drug-Eluting Devices Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Peripheral Intervention Drug-Eluting Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Peripheral Intervention Drug-Eluting Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Peripheral Intervention Drug-Eluting Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Medtronic plc Corporation Information
Table 43. Medtronic plc Description and Business Overview
Table 44. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product
Table 46. Medtronic plc Recent Development
Table 47. Boston Scientific Corporation Corporation Information
Table 48. Boston Scientific Corporation Description and Business Overview
Table 49. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Boston Scientific Corporation Product
Table 51. Boston Scientific Corporation Recent Development
Table 52. Abbott Laboratories Corporation Information
Table 53. Abbott Laboratories Description and Business Overview
Table 54. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Abbott Laboratories Product
Table 56. Abbott Laboratories Recent Development
Table 57. Cardinal Health Corporation Information
Table 58. Cardinal Health Description and Business Overview
Table 59. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Cardinal Health Product
Table 61. Cardinal Health Recent Development
Table 62. B. Braun Melsungen AG Corporation Information
Table 63. B. Braun Melsungen AG Description and Business Overview
Table 64. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. B. Braun Melsungen AG Product
Table 66. B. Braun Melsungen AG Recent Development
Table 67. Biosensors International Group Ltd. Corporation Information
Table 68. Biosensors International Group Ltd. Description and Business Overview
Table 69. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Biosensors International Group Ltd. Product
Table 71. Biosensors International Group Ltd. Recent Development
Table 72. C.R. Bard, Inc. Corporation Information
Table 73. C.R. Bard, Inc. Description and Business Overview
Table 74. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. C.R. Bard, Inc. Product
Table 76. C.R. Bard, Inc. Recent Development
Table 77. Abbott Corporation Information
Table 78. Abbott Description and Business Overview
Table 79. Abbott Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Abbott Product
Table 81. Abbott Recent Development
Table 82. The Lubrizol Corporation Corporation Information
Table 83. The Lubrizol Corporation Description and Business Overview
Table 84. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. The Lubrizol Corporation Product
Table 86. The Lubrizol Corporation Recent Development
Table 87. Terumo Corporation Corporation Information
Table 88. Terumo Corporation Description and Business Overview
Table 89. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Terumo Corporation Product
Table 91. Terumo Corporation Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Peripheral Intervention Drug-Eluting Devices Customers List
Table 95. Peripheral Intervention Drug-Eluting Devices Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Peripheral Intervention Drug-Eluting Devices Product Picture
Figure 2. Global Peripheral Intervention Drug-Eluting Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Peripheral Intervention Drug-Eluting Devices Market Size 2017-2028 (US$ Million)
Figure 4. Global Peripheral Intervention Drug-Eluting Devices Sales 2017-2028 (K Units)
Figure 5. United States Peripheral Intervention Drug-Eluting Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Peripheral Intervention Drug-Eluting Devices Market Size 2017-2028 (US$ Million)
Figure 7. United States Peripheral Intervention Drug-Eluting Devices Sales 2017-2028 (K Units)
Figure 8. United States Peripheral Intervention Drug-Eluting Devices Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Peripheral Intervention Drug-Eluting Devices Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Peripheral Intervention Drug-Eluting Devices Report Years Considered
Figure 11. Product Picture of Drug-Eluting Balloons
Figure 12. Product Picture of Drug-Eluting Stents
Figure 13. Global Peripheral Intervention Drug-Eluting Devices Market Share by Type in 2022 & 2028
Figure 14. Global Peripheral Intervention Drug-Eluting Devices Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2028) & (K Units)
Figure 17. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Peripheral Intervention Drug-Eluting Devices Price by Type (2017-2028) & (USD/Unit)
Figure 19. United States Peripheral Intervention Drug-Eluting Devices Market Share by Type in 2022 & 2028
Figure 20. United States Peripheral Intervention Drug-Eluting Devices Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Peripheral Intervention Drug-Eluting Devices Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2028) & (K Units)
Figure 23. United States Peripheral Intervention Drug-Eluting Devices Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Peripheral Intervention Drug-Eluting Devices Price by Type (2017-2028) & (USD/Unit)
Figure 25. Product Picture of Plain Old Balloon Angioplasty (POBA)
Figure 26. Product Picture of Percutaneous Transluminal Angioplasty (PTA)
Figure 27. Global Peripheral Intervention Drug-Eluting Devices Market Share by Application in 2022 & 2028
Figure 28. Global Peripheral Intervention Drug-Eluting Devices Sales in Value by Application (2017-2028) & (US$ Million)
Figure 29. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share in Value by Application (2017-2028)
Figure 30. Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2028) & (K Units)
Figure 31. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share in Volume by Application (2017-2028)
Figure 32. Global Peripheral Intervention Drug-Eluting Devices Price by Application (2017-2028) & (USD/Unit)
Figure 33. United States Peripheral Intervention Drug-Eluting Devices Market Share by Application in 2022 & 2028
Figure 34. United States Peripheral Intervention Drug-Eluting Devices Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. United States Peripheral Intervention Drug-Eluting Devices Sales Market Share in Value by Application (2017-2028)
Figure 36. United States Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2028) & (K Units)
Figure 37. United States Peripheral Intervention Drug-Eluting Devices Sales Market Share in Volume by Application (2017-2028)
Figure 38. United States Peripheral Intervention Drug-Eluting Devices Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Peripheral Intervention Drug-Eluting Devices Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 40. North America Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 41. U.S. Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 42. Canada Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Europe Peripheral Intervention Drug-Eluting Devices Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 44. Europe Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. Germany Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. France Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. U.K. Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Italy Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Russia Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 51. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. China Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Japan Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. South Korea Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. India Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Australia Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Taiwan Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Indonesia Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Thailand Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Malaysia Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Philippines Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Latin America Peripheral Intervention Drug-Eluting Devices Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 63. Latin America Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 64. Mexico Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Brazil Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Argentina Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 68. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Turkey Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Saudi Arabia Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. U.A.E Peripheral Intervention Drug-Eluting Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Peripheral Intervention Drug-Eluting Devices Value Chain
Figure 73. Peripheral Intervention Drug-Eluting Devices Production Process
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed